Published in Hum Genomics on November 01, 2003
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol (1971) 37.53
Promotion of microtubule assembly in vitro by taxol. Nature (1979) 12.73
Searching for peptide ligands with an epitope library. Science (1990) 10.75
Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem (1987) 10.61
A hot spot of binding energy in a hormone-receptor interface. Science (1995) 10.41
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature (1996) 8.37
Drug discovery: a historical perspective. Science (2000) 8.15
Natural products as sources of new drugs over the period 1981-2002. J Nat Prod (2003) 8.03
The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature (1998) 6.69
Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol (1999) 6.62
Fluoroquinolone antimicrobial agents. Clin Microbiol Rev (1989) 6.45
Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell (1997) 5.73
TTD: Therapeutic Target Database. Nucleic Acids Res (2002) 4.91
Folding funnels, binding funnels, and protein function. Protein Sci (1999) 4.22
Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science (1996) 3.94
Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother (1996) 3.86
Structure of a bacterial quorum-sensing transcription factor complexed with pheromone and DNA. Nature (2002) 3.45
Protein analysis on a proteomic scale. Nature (2003) 3.12
Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res (1996) 3.00
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J (1999) 2.81
Solution structure of the antiapoptotic protein bcl-2. Proc Natl Acad Sci U S A (2001) 2.60
DNA gyrase as a drug target. Trends Microbiol (1997) 2.55
Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem (1997) 2.47
Antibiotic inhibition of group I ribozyme function. Nature (1991) 2.44
Folding and binding cascades: shifts in energy landscapes. Proc Natl Acad Sci U S A (1999) 2.37
Microbial cell-surface display. Trends Biotechnol (2003) 2.13
Binding of neomycin to phosphatidylinositol 4,5-bisphosphate (PIP2). Biochim Biophys Acta (1989) 2.13
Interaction of antibiotics with A- and P-site-specific bases in 16S ribosomal RNA. EMBO J (1991) 1.96
Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J Biol Chem (1997) 1.93
The propagation of binding interactions to remote sites in proteins: analysis of the binding of the monoclonal antibody D1.3 to lysozyme. Proc Natl Acad Sci U S A (1999) 1.87
Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res (1989) 1.82
ParC and GyrA may be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniae. Antimicrob Agents Chemother (1999) 1.81
Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel. J Biol Chem (2002) 1.80
Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc Natl Acad Sci U S A (1999) 1.72
An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication. Proc Natl Acad Sci U S A (1997) 1.70
Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol Med (1995) 1.65
The penicillins. Mayo Clin Proc (1999) 1.63
Discovery of novel targets of quinoline drugs in the human purine binding proteome. Mol Pharmacol (2002) 1.59
Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun (1988) 1.43
Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. Cancer Res (1998) 1.40
Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide. Proc Natl Acad Sci U S A (1999) 1.40
Evidence that a protein-protein interaction 'hot spot' on heterotrimeric G protein betagamma subunits is used for recognition of a subclass of effectors. EMBO J (2001) 1.39
Mechanisms of action of flavopiridol. Crit Rev Oncol Hematol (2001) 1.33
Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein. J Mol Biol (1999) 1.31
mRNA display: ligand discovery, interaction analysis and beyond. Trends Biochem Sci (2003) 1.29
Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region. Biochemistry (1997) 1.21
HIV protease inhibitors block adipogenesis and increase lipolysis in vitro. Antiviral Res (2000) 1.15
Quantitative assessment of peptide sequence diversity in M13 combinatorial peptide phage display libraries. J Mol Biol (2002) 1.15
Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach. J Mol Graph Model (2001) 1.12
Inhibition of RNase P RNA cleavage by aminoglycosides. Proc Natl Acad Sci U S A (1999) 1.09
The mechanism of inhibition of beta-oxidation by aspirin metabolites in skin fibroblasts from Reye's syndrome patients and controls. Biochim Biophys Acta (1999) 1.06
A specific inhibitor for tyrosine protein kinase from Pseudomonas. J Antibiot (Tokyo) (1986) 1.06
Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death. Hear Res (2002) 1.05
Display cloning: functional identification of natural product receptors using cDNA-phage display. Chem Biol (1999) 1.05
Alternative bacteriophage display systems. Comb Chem High Throughput Screen (2001) 1.04
Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells. FEBS Lett (2002) 1.01
Effects of peroxisome proliferators on fatty acid-binding protein in rat liver. Biochim Biophys Acta (1983) 0.99
Ligands differentially modulate the protein interactions of the human estrogen receptors alpha and beta. J Mol Biol (2003) 0.98
Drug receptor identification from multiple tissues using cellular-derived mRNA display libraries. Chem Biol (2002) 0.93
Computer systems for the prediction of toxicity: an update. Adv Drug Deliv Rev (2002) 0.92
High affinity RNase S-peptide variants obtained by phage display have a novel "hot-spot" of binding energy. Biochemistry (2001) 0.91
Gene VIII-based, phage-display vectors for selection against complex mixtures of ligands. Biotechniques (1998) 0.91
Identification of natural ligands for SH2 domains from a phage display cDNA library. J Mol Biol (2000) 0.90
Identification of hNopp140 as a binding partner for doxorubicin with a phage display cloning method. Chem Biol (2002) 0.90
Loss of the bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis. Biochem Biophys Res Commun (1999) 0.89
Flavopiridol binds to duplex DNA. Cancer Res (2000) 0.89
Mapping of epitopes recognized by PM/Scl autoantibodies with gene-fragment phage display libraries. J Immunol Methods (1996) 0.88
Antigen-dependent and -independent IFN-gamma modulation by penicillins. J Immunol (1999) 0.87
Use of a pharmacophore model for the design of EGFR tyrosine kinase inhibitors: isoflavones and 3-phenyl-4(1H)-quinolones. J Med Chem (1999) 0.87
Block of the alpha9 nicotinic receptor by ototoxic aminoglycosides. Neuropharmacology (2000) 0.85
Mechanism of action of nonsteroidal anti-inflammatory agents. Am J Med (1984) 0.84
A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry. Mol Pharmacol (2000) 0.84
Inhibition of human liver steroid sulfotransferase activities by drugs: a novel mechanism of drug toxicity? Eur J Pharmacol (1992) 0.84
The inhibitory activity of a peptide derivative against the growth of simian immunodeficiency virus in C8166 cells. Biochem Biophys Res Commun (1991) 0.83
Dual cytotoxic mechanisms of submicromolar taxol on human leukemia HL-60 cells. Biochem Pharmacol (1997) 0.82
Identification of small molecule binding sites within proteins using phage display technology. Comb Chem High Throughput Screen (2001) 0.82
Valdecoxib: a review. Clin Ther (2003) 0.82
Cloning of open reading frames and promoters from the Saccharomyces cerevisiae genome: construction of genomic libraries of random small fragments. Gene (1986) 0.81
Phage display cDNA cloning of protein with carbohydrate affinity. Biochem Biophys Res Commun (1999) 0.81
Identification of the domains of photoincorporation of the 3'- and 7-benzophenone analogues of taxol in the carboxyl-terminal half of murine mdr1b P-glycoprotein. Biochemistry (1998) 0.81
New drug development in the United States from 1963 to 1990. Clin Pharmacol Ther (1991) 0.80
DNA gyrase activities from Rhodobacter capsulatus: analysis of target(s) of coumarins and cloning of the gyrB locus. FEMS Microbiol Lett (1992) 0.78
Affinity selection of DNA-binding proteins from yeast genomic DNA libraries by improved lambda phage display vector. J Biochem (2002) 0.78
Acetylation of antithrombin III by aspirin. Semin Thromb Hemost (1986) 0.78
In vitro interaction of penicillins and cephalosporins with human placenta GSH S-transferase. Res Commun Chem Pathol Pharmacol (1984) 0.78
A unique paclitaxel-mediated modulation of the catalytic activity of topoisomerase IIalpha. Anticancer Drugs (1999) 0.77
Nonsteroidal anti-inflammatory drugs activate carbonic anhydrase by a direct mechanism of action. J Pharmacol Exp Ther (1996) 0.77
Corrigendum to: "Display cloning: functional identification of natural product receptors using cDNA-phage display" [Chemistry & Biology 6 (1999) 707-716]. Chem Biol (2001) 0.77
Biotechnology match making: screening orphan ligands and receptors. Curr Opin Biotechnol (2000) 0.77
Computer-aided prediction of drug toxicity and metabolism. EXS (2003) 0.76
Role of predictive metabolism and toxicity modeling in drug discovery--a summary of some recent advancements. Curr Opin Drug Discov Devel (2003) 0.76
Understanding clinical trials. Sci Am (2000) 0.76
Selection and identification of dense granule antigen GRA3 by Toxoplasma gondii whole genome phage display. J Biol Chem (2002) 0.76
Differential in vivo and in vitro effect of gentamicin on glutamate synthesis and glutamate deamination in rabbit kidney-cortex tubules and mitochondria. Pharmacol Res (1992) 0.76
Gentamicin induced inhibition of steroidogenic enzymes in rat testis. Indian J Physiol Pharmacol (1999) 0.76
Molecular crowding inhibits intramolecular breathing motions in proteins. J Mol Biol (2007) 1.46
RELIC--a bioinformatics server for combinatorial peptide analysis and identification of protein-ligand interaction sites. Proteomics (2004) 1.42
High-resolution wide-angle X-ray scattering of protein solutions: effect of beam dose on protein integrity. J Synchrotron Radiat (2003) 1.22
Characterization of protein fold by wide-angle X-ray solution scattering. J Mol Biol (2008) 1.00
Subtractive transcriptomics: establishing polarity drives in vitro human endothelial morphogenesis. Cancer Res (2006) 0.93
X-ray solution scattering studies of the structural diversity intrinsic to protein ensembles. Biopolymers (2011) 0.92
Phage display reveals multiple contact sites between FhuA, an outer membrane receptor of Escherichia coli, and TonB. J Mol Biol (2005) 0.90